ClinConnect ClinConnect Logo
Search / Trial NCT01499082

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

Launched by SANOFI · Dec 21, 2011

Trial Information

Current as of August 02, 2025

Completed

Keywords

ClinConnect Summary

The maximum study duration was up to approximately 58 weeks per participant, consisting of:

* up to 2 week screening period
* 6-month comparative efficacy and safety treatment period
* 6-month comparative safety extension period
* 4-week safety follow-up period in a subset of participants
* a 3-month administration substudy period starting after completion of the 6-month study period for participants willing to in a subset of participants randomized to HOE901-U300

Gender

ALL

Eligibility criteria

  • Inclusion criteria :
  • Participants with type 2 diabetes mellitus
  • * Substudy inclusion criteria:
  • Completion of the 6-month study period in main study (Visit 10)
  • Randomized and treated with insulin glargine new formulation during the 6-month treatment period (Baseline - month 6)
  • Exclusion criteria:
  • Age less than (\<) 18 years
  • HbA1c \<7.0% or greater than (\>) 10% at screening
  • Diabetes other than type 2 diabetes mellitus
  • Less than 1 year on basal plus mealtime insulin and self-monitoring of blood glucose
  • Any contraindication to use of insulin glargine as defined in the national product label
  • Participants using human regular insulin as mealtime insulin in the last 3 months before screening visit
  • Use of an insulin pump in the last 6 months before screening visit
  • Initiation of new glucose-lowering agents and/or weight loss drugs in the last 3 months before screening visit
  • History or presence of significant diabetic retinopathy or macular edema likely to require laser or injectable drugs or surgical treatment during the study period
  • Pregnant or breast-feeding women or women who intend to become pregnant during the study period
  • * Substudy exclusion criteria:
  • Participant not willing to use the adaptable injection intervals on at least two days per week
  • The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

About Sanofi

Sanofi is a global healthcare leader dedicated to empowering life through innovation in pharmaceuticals and vaccines. With a strong commitment to research and development, Sanofi focuses on addressing complex health challenges across various therapeutic areas, including diabetes, oncology, immunology, and rare diseases. The company leverages advanced science and technology to develop transformative therapies that improve patient outcomes. Through collaborative partnerships and a patient-centric approach, Sanofi strives to enhance global health and deliver sustainable solutions that meet the evolving needs of healthcare systems and communities worldwide.

Locations

Rapid City, South Dakota, United States

Montreal, , Canada

Dallas, Texas, United States

Oulu, , Finland

Oradea, , Romania

Tallinn, , Estonia

Chandler, Arizona, United States

Glendale, Arizona, United States

Phoenix, Arizona, United States

Sun City, Arizona, United States

Tempe, Arizona, United States

Hot Springs, Arkansas, United States

Little Rock, Arkansas, United States

Little Rock, Arkansas, United States

Searcy, Arkansas, United States

Anaheim, California, United States

Encino, California, United States

Greenbrae, California, United States

Huntington Beach, California, United States

La Jolla, California, United States

La Mesa, California, United States

Mission Hills, California, United States

Palm Springs, California, United States

San Diego, California, United States

Tustin, California, United States

Walnut Creek, California, United States

Colorado Springs, Colorado, United States

Colorado Springs, Colorado, United States

Longmont, Colorado, United States

Daytona Beach, Florida, United States

Hollywood, Florida, United States

Jacksonville, Florida, United States

Jacksonville, Florida, United States

Jacksonville, Florida, United States

New Port Richey, Florida, United States

Ocoee, Florida, United States

Palm Harbor, Florida, United States

Lawrenceville, Georgia, United States

Idaho Falls, Idaho, United States

Nampa, Idaho, United States

Mchenry, Illinois, United States

Springfield, Illinois, United States

Avon, Indiana, United States

Avon, Indiana, United States

Avon, Indiana, United States

Avon, Indiana, United States

Avon, Indiana, United States

Vincennes, Indiana, United States

Des Moines, Iowa, United States

Wichita, Kansas, United States

Lexington, Kentucky, United States

Paducah, Kentucky, United States

Baltimore, Maryland, United States

Baltimore, Maryland, United States

Rockville, Maryland, United States

Ann Arbor, Michigan, United States

Dearborn, Michigan, United States

Flint, Michigan, United States

Kalamazoo, Michigan, United States

Southfield, Michigan, United States

Chaska, Minnesota, United States

Eagan, Minnesota, United States

Minneapolis, Minnesota, United States

Kalispell, Montana, United States

Fremont, Nebraska, United States

Omaha, Nebraska, United States

Las Vegas, Nevada, United States

Brick, New Jersey, United States

Toms River, New Jersey, United States

Asheville, North Carolina, United States

Hickory, North Carolina, United States

Wilmington, North Carolina, United States

Fargo, North Dakota, United States

Cincinnati, Ohio, United States

Columbus, Ohio, United States

Dayton, Ohio, United States

Maumee, Ohio, United States

Mentor, Ohio, United States

Medford, Oregon, United States

Portland, Oregon, United States

Uniontown, Pennsylvania, United States

Greer, South Carolina, United States

Chattanooga, Tennessee, United States

Knoxville, Tennessee, United States

Austin, Texas, United States

Austin, Texas, United States

Austin, Texas, United States

Dallas, Texas, United States

Houston, Texas, United States

Hurst, Texas, United States

Draper, Utah, United States

Ogden, Utah, United States

Chesapeake, Virginia, United States

Norfolk, Virginia, United States

Norfolk, Virginia, United States

Norfolk, Virginia, United States

Richmond, Virginia, United States

Williamsburg, Virginia, United States

Milwaukee, Wisconsin, United States

Beamsville, , Canada

Burlington, , Canada

Calgary, , Canada

Calgary, , Canada

Chatham, , Canada

Coquitlam, , Canada

Hamilton, , Canada

Hamilton, , Canada

Laval, , Canada

London, , Canada

Mississauga, , Canada

Montreal, , Canada

Oshawa, , Canada

Quebec, , Canada

Red Deer, , Canada

Thornhill, , Canada

Toronto, , Canada

Toronto, , Canada

Victoria, , Canada

Ville St Laurent, , Canada

Winnipeg, , Canada

Beroun, , Czechia

Breclav, , Czechia

Hodonin, , Czechia

Holesov, , Czechia

Hradec Kralove, , Czechia

Hranice, , Czechia

Krnov, , Czechia

Olomouc, , Czechia

Praha 2, , Czechia

Prostejov, , Czechia

Pärnu, , Estonia

Tallinn, , Estonia

Tallinn, , Estonia

Tallinn, , Estonia

Tartu, , Estonia

Helsinki, , Finland

Kuopio, , Finland

La Rochelle Cedex, , France

Strasbourg, , France

Heidelberg, , Germany

Riesa, , Germany

Schwabenheim, , Germany

Baja, , Hungary

Balatonfüred, , Hungary

Budapest, , Hungary

Budapest, , Hungary

Budapest, , Hungary

Budapest, , Hungary

Budapest, , Hungary

Debrecen, , Hungary

Eger, , Hungary

Gyula, , Hungary

Makó, , Hungary

Mosonmagyaróvár, , Hungary

Nyiregyháza, , Hungary

Szeged, , Hungary

Szombathely, , Hungary

Sátorlaljaújhely, , Hungary

Zalaegerszeg, , Hungary

Jekabpils, , Latvia

Ogre, , Latvia

Riga, , Latvia

Riga, , Latvia

Riga, , Latvia

Sigulda, , Latvia

Chihuahua, , Mexico

Cuernavaca, , Mexico

Guadalajara, , Mexico

Monterrey, , Mexico

Pachuca, , Mexico

Almelo, , Netherlands

Eindhoven, , Netherlands

Groningen, , Netherlands

Hoogeveen, , Netherlands

Hoorn, , Netherlands

Leeuwarden, , Netherlands

Utrecht, , Netherlands

Venlo, , Netherlands

Bacau, , Romania

Bucuresti, , Romania

Bucuresti, , Romania

Cluj Napoca, , Romania

Iasi, , Romania

Iasi, , Romania

Targu Mures, , Romania

Timisoara, , Romania

Alberton, , South Africa

Johannesburg, , South Africa

Lenasia, , South Africa

Observatory, , South Africa

Paarl, , South Africa

Pretoria, , South Africa

Somerset West, , South Africa

Patients applied

0 patients applied

Trial Officials

Clinical Sciences & Operations

Study Director

Sanofi

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials